King V R, Bradbury E J, McMahon S B, Priestley J V
Neuroscience Section, Division of Biomedical Sciences, Queen Mary and Westfield College, Mile End Road, London, E1 4NS, United Kingdom.
Exp Neurol. 2000 Oct;165(2):327-41. doi: 10.1006/exnr.2000.7480.
Although numerous studies have examined the effects of neurotrophin treatment following spinal cord injury, few have examined the changes that occur in the neurotrophin receptors following either such damage or neurotrophin treatment. To determine what changes occur in neurotrophin receptor expression following spinal cord damage, adult rats received a midthoracic spinal cord hemisection alone or in combination with intrathecal application of brain-derived neurotrophic factor (BDNF) or neurotrophin-3 (NT-3). Using immunohistochemical and in situ hybridization techniques, p75, trkA, trkB, and trkC receptor expression was examined throughout the spinal cord. Results showed that trkA, full-length trkB, and trkC receptors were not present in the lesion site but had a normal expression pattern in uninjured parts of the spinal cord. In contrast, p75 receptor expression occurred on Schwann cells throughout the lesion site. BDNF and NT-3 (but not saline) applied to the lesion site increased this expression. In addition, the truncated trkB receptor was expressed in the border between the lesion and intact spinal cord. Truncated trkB receptor expression was also increased throughout the white matter ipsilateral to the lesion and BDNF (but not NT-3 or saline) prevented this increase. The study is the first to show changes in truncated trkB receptor expression that extend beyond the site of a spinal cord lesion and is one of the first to show that BDNF and NT-3 affect Schwann cells and/or p75 expression following spinal cord damage. These results indicate that changes in neurotrophin receptor expression following spinal cord injury could influence the availability of neurotrophins at the lesion site. In addition, neurotrophins may affect their own availability to damaged neurons by altering the expression of the p75 and truncated trkB receptor.
尽管众多研究已探讨了脊髓损伤后神经营养因子治疗的效果,但很少有研究考察此类损伤或神经营养因子治疗后神经营养因子受体的变化。为了确定脊髓损伤后神经营养因子受体表达发生了哪些变化,成年大鼠接受了胸段脊髓半横断术,单独进行或联合鞘内注射脑源性神经营养因子(BDNF)或神经营养因子-3(NT-3)。运用免疫组织化学和原位杂交技术,对整个脊髓中的p75、trkA、trkB和trkC受体表达进行了检测。结果显示,trkA、全长trkB和trkC受体在损伤部位不存在,但在脊髓未损伤部分具有正常的表达模式。相比之下,p75受体表达出现在整个损伤部位的雪旺细胞上。应用于损伤部位的BDNF和NT-3(而非生理盐水)增加了这种表达。此外,截短的trkB受体在损伤与完整脊髓之间的边界处表达。截短的trkB受体表达在损伤同侧的整个白质中也增加了,并且BDNF(而非NT-3或生理盐水)阻止了这种增加。该研究首次表明截短的trkB受体表达的变化超出了脊髓损伤部位,并且是首批表明BDNF和NT-3在脊髓损伤后影响雪旺细胞和/或p75表达的研究之一。这些结果表明,脊髓损伤后神经营养因子受体表达的变化可能会影响损伤部位神经营养因子的可利用性。此外,神经营养因子可能通过改变p75和截短的trkB受体的表达来影响其自身对受损神经元的可利用性。